Abstract
Immune Reconstitution Inflammatory Syndrome in a HIV-Negative Patient Presenting as Type 1 Leprosy Reaction: A Rare Case Report
Department of Dermatology, Seth GS Medical College and KEM Hospital, Mumbai, India
Department of Dermatology, P. D. Hinduja Hospital and Medical Research Centre, Mumbai, India
Dermatol Rev/Przegl Dermatol 2026, 113, 256–260
Immune reconstitution inflammatory syndrome is a clinical phenomenon characterized by immune-mediated inflammation against various antigens, including pathogenic microorganisms, drugs and unknown autoantigens, during recovery from immunosuppressed states such as HIV infection, internal malignancies, autoimmune diseases, and severe cutaneous adverse drug reactions. Immune reconstitution inflammatory syndrome is a well-recognized entity in the HIV-infected population. However, it has rarely been recognized in HIV-negative immunocompromised patients. Potential scenarios of immune recovery include discontinuation or abrupt tapering of systemic corticosteroids and/or immunosuppressants, withdrawal or reduced effects of anti-tumor necrosis factor-α antibodies, and the use of immune checkpoint inhibitors in advanced malignancies. To the best of our knowledge, there are no previous reports of a type 1 leprosy reaction associated with immune reconstitution inflammatory syndrome in an HIV-negative patient. We present a case of immune reconstitution inflammatory syndrome manifesting as a type 1 leprosy reaction in a patient with rectal carcinoma treated with neoadjuvant chemotherapy and radiotherapy.
Keywords
type 1 leprosy reaction, immune reconstitution inflammatory syndrome, HIV-negative, rectal carcinoma, chemotherapy
Coverage in
Integrated with

